The much-awaited guidance on interchangeability the FDA promised last year? It's now on the schedule for 2015, along with other biosimilar draft guidances on labeling, statistical approaches for evaluating analytical similarity data and implementation of the Biologic Price Competition and Innovation Act (BPCIA).